Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor: Molecular Therapy
HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen: Molecular Therapy - Oncolytics
Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center
HLA-DR Antibodies - Beckman Coulter Life Sciences
Bone Marrow Donor Programme (Singapore) - HLA matching is used to match patients and donors for bone marrow transplants. There are many HLA markers, and each marker has a name. The names
HLA typing in cancer
Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy | Molecular Medicine | Full Text
Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering | Experimental & Molecular Medicine
Human leukocyte antigen - Wikipedia
Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research
Why HLA?
HLA Matching
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells - ScienceDirect
HLA LOH Monitoring — JETA Molecular
What is HLA Typing And Why You Should Have Your Cells Genotyped?
Differential expression of several surface markers on HLA-DR+ and... | Download Scientific Diagram
Frontiers | HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation
Frontiers | Regulation of NK-Cell Function by HLA Class II
HLA typed cancer cells
HLA-typed cells and their role in immunotherapy - PromoCell
HLA Gene May Predict if Cancer Immunotherapy Will Work - NCI
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Human T cells recognize HLA-DP–bound peptides in two orientations | PNAS
HLA typing in cancer
